Castle Family Health Centers, Inc At Castle

CLIA Laboratory Citation Details

2
Total Citations
3
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 05D0900020
Address 3605 Hospital Rd, Atwater, CA, 95301
City Atwater
State CA
Zip Code95301
Phone(209) 726-1235

Citation History (2 surveys)

Survey - November 17, 2022

Survey Type: Standard

Survey Event ID: GG8911

Deficiency Tags: D2100 D6029

Summary:

Summary Statement of Deficiencies D2100 ENDOCRINOLOGY CFR(s): 493.843(c) Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Consideration may be given to those laboratories failing to participate in a testing event only if-- (1) Patient testing was suspended during the time frame allotted for testing and reporting proficiency testing results; (2) The laboratory notifies the inspecting agency and the proficiency testing program within the time frame for submitting proficiency testing results of the suspension of patient testing and the circumstances associated with failure to perform tests on proficiency testing samples; and (3) The laboratory participated in the previous two proficiency testing events. This STANDARD is not met as evidenced by: Based on review of 2021 proficiency testing reports from CMS [report 155D, Individual Laboratory Profile] and AAB [American Academy of Bioanalysts], the lack of laboratory proficiency testing records, and interview with Testing person-1, it was determined the laboratory failed to participate in proficiency testing for serum HCG [pregnancy test]. Findings included: 1. CMS and AAB reported scores for HCG, as follows: 2021: Event 2 Event 3 ------------------------------ 0% 0% 2. The laboratory failed to have records of testing for the aforementioned events, and failed to have records notifying AAB of the circumstances for not testing; and thus, resulted in scores of 0%. 3. Testing person-1 affirmed (11/17/22 at 1pm) the laboratory didn't participate in proficiency testing of serum HCG in 2021, events 2 and 3. 4. The reliability and quality of serum HCG results reported after 2/17/21 [event 1] could not be assured. D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on review of Personnel Reports [forms CMS209, LAB116; 11/15/22] and laboratory test records, the lack of laboratory training records, and interview with Testing persons 2, 3, and 4, it was determined that the Laboratory Director was deficient in establishing policy and records to monitor and ensure all personnel were trained and demonstrated satisfactory operation of laboratory analyzers and manual tests performances prior to testing patients' specimen. Findings included: 1. Laboratory Personnel Reports documented four testing persons. 2. Laboratory test records documented testing persons, as follows: Date ID Testing person ---------------------------------------------------------- 7/29/20 0729:H00006R 2 11/04/20 1104:H00003R 2 2/08/21 0208:C00005R 2 6/23/21 0623:H00056R 2 5/26/22 0526: H00023R 2, 3 8/10/22 0810:H00001R 2, 3 11/03/22 1103:H00005R 2, 3, 4 3. Testing person-2 affirmed (11/17/22 at 5pm) the hire date in 2020, but was unable to provide records of training and demonstrating reliable testing prior to testing patients' specimen. 4. Testing person-3 affirmed (11/17/22 at 5pm) the hire date of 3/21/22 and provided a record of training in chemistry testing only, but no records for demonstrating reliable testing prior to testing patients' specimen. 5. Testing person-4 affirmed (11/17/22 at 5pm) the hire date prior to 2020, but was unable to provide any records of training and demonstrating reliable testing prior to testing patient's specimen. 6. And thus, the reliability and quality of training and subsequent test results reported could not be assured. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 18, 2019

Survey Type: Standard

Survey Event ID: 9ERL11

Deficiency Tags: D2121

Summary:

Summary Statement of Deficiencies D2121 HEMATOLOGY CFR(s): 493.851(a) Failure to attain a score of at least 80 percent of acceptable responses for each analyte in each testing event is unsatisfactory analyte performance for the testing event. This STANDARD is not met as evidenced by: Based on observation of a Sysmex 600 series analyzer for coagulation testing, review of 2018 proficiency testing reports from CMS (report 155D, Individual Laboratory Profile) and AAB (American Association of Bioanalysts), laboratory proficiency testing records, and patients results; and interview with laboratory personnel, it was revealed that the laboratory failed to attain a score of at least 80% for Prothrombin Time (Coagulation test). Findings included: a. CMS and AAB reported the unsatisfactory score of 60% for event 2 of 2018 for Prothrombin Time. b. Laboratory proficiency testing records showed all 5 results were low compared to to the Mean, and that 2 were unacceptable: Sample Lab result Mean Acceptable Range -------------------------------------------------------------- 1 16.9 19.95 17.0 - 22.9 2 11.0 12.08 10.3 - 13.9 3 22.0 26.19 22.3 - 30.1 4 10.4 11.06 9.4 - 12.7 5 10.3 11.65 9.9 - 13.4 b. Laboratory personnel affirmed (8/15/19 at 3pm) the aforementioned findings. c. The reliability and quality of results reported for patients could not be assured when proficiency testing indicated testing was unsatisfactory and results were too short. A few examples selected at random from the timeframe May - September 2018 were as follows: Date Spec # ------------------------------------------ 5/18/18 0518 : CG00001R 6 /20/18 0620 : CG00003R 7/06/18 0706 : CG00005R 8/27/18 0827 : CG00002R 9/10 /18 0910 : CG00002R . Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access